Superoxidase dismutase (SOD) topical use in oncologic patients: Treatment of acute cutaneous toxicity secondary to radiotherapy

Clinical and Translational Oncology

Volumn 10, Issue 3, 2008, Pages 163-167

  García, Álvaro Manzanas ^a   López Carrizosa, María Concepción ^b   Vallejo Ocaña, Carmen ^b   Samper Ots, Pilar ^b   Delgado Pérez, José María ^b   Carretero Accame, Emilia ^a   Gómez Serranillos, Pilar ^a   Morena del Valle, Luis ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b HOSPITAL CENTRAL DE LA DEFENSA GÓMEZ ULLA   (Spain)

Author keywords

Orgotein; Radiodermatitis; Superoxide dismutase; Topical route

Indexed keywords

SUPEROXIDE DISMUTASE; SCAVENGER;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PATIENT; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; RADIATION DERMATITIS; RADIATION DOSE FRACTIONATION; TREATMENT DURATION; TUMOR LOCALIZATION; ACUTE DISEASE; MIDDLE AGED; NEOPLASM; OINTMENT; RADIATION EXPOSURE; RADIOTHERAPY; SKIN; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ACUTE DISEASE; ADMINISTRATION, TOPICAL; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FREE RADICAL SCAVENGERS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; OINTMENTS; RADIODERMATITIS; RADIOTHERAPY; SKIN; SUPEROXIDE DISMUTASE; TREATMENT OUTCOME;

EID: 45549101511     PISSN: 1699048X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12094-008-0174-0     Document Type: Article

References (26)

1. Nakano T, Oka K, Taniguchi N (1996) Manganese superoxide dismutase expression correlates with p53 status and local recurrence of cervical carcinoma treated with radiation therapy. Cancer Res 56:2771-2775
2. Buell MG, Hording RK (1989) Proinflammatory effects of local abdominal irradiation on rat GI tract. Dig Dis Sci 34:390-399
3. De AK, Rajan RR, Krishnamoorthy L et al (1995) Oxidative stress in radiation-induced interstitial pneumonitis in the rat. Int J Radiat Biol 68:405-409
4. Epperly M, Bray J, Kraeger S et al (1998) Prevention of late effects of irradiation lung damage by manganese superoxide dismutase gene therapy. Gen Ther 5:196-208
5. McCord JM, Fridovich I (1969) Superoxide dismutase: An enzymatic function for erythrocuprein (hemocuprein). J Biol Chem 244:6049-6055
6. Esco R, Valencia J, Bascon N et al (2003) Prevención de toxicidad rectal tardía radioinducida. Estudio randomizado. Rev Oncología 5:190
7. Esco R, Valencia J, Bascon N et al (2003) Estudio randomizado de prevención de toxicidad radioinducida tardía pélvica mediante Ontosein®. Rev Oncología 5:190
8. Valencia J, Polo S, Velilla C et al (2001) Impacto del uso de orgoteina en la prevención de esofagitis por irradiación en el carcinoma microcítico pulmonar. Rev Oncología 3:204
9. Valencia J, Polo S, Bascon N et al (2000) Orgoteina asociada a radioterapia en cancer de cabeza y cuello. Control de la toxicidad. Rev Oncología 2:137
10. Edsmyr F, Menander Huber KB (1981) Orgotein efficacy in ameliorating side effects due to radiation therapy. Eur J Rheum Inflamm 4:228-236
11. Edsmyr F, Huber W, Menander KB (1976) Orgotein efficacy in ameliorating side effects due to radiation therapy. Double-blind, placebo-controlled trial in patients with bladder tumors. Curr Ther Res 19:198-211
12. Maberger H, Hubert W, Menandert Hubert KB, Bartsch G (1981) Orgotein: A new drug for the treatment of radiation cystitis. Eur J Rheum Inflamm 4:244-249
13. Menander Huber KB, Edsmyr F, Huber W (1980) Orgotein efficacy in ameliorating side effects due to radiation therapy. Scand J Urol Nephrol 55:219-224
14. Vaca JM, Vegas M, Merino R (1997) Epidural orgotein in failed back syndrome. II Congress of the European Federation of IAPS 1997. Barcelona, Spain
15. Ruiz A, Gil R (1999) Tratamiento del dolor mediante administración intradérmica de una solución compuesta por anestésico local+antiinflamatorio+ analgésico. IV congreso de la SED, Málaga, Spain
16. Reig E (1994) Sistemas de infusión de fármacos en el tratamiento del dolor. Rev Soc Esp Dolor 1:14-20
17. Rodríguez-López M, Camba A, Contreras D, Torres LM (2003) Multicenter clinical trial of epidural orgotein versus placebo in patients with chronic intractable spinal pain. Pain Clin 15:7-15
18. Rubin P, Constine LS, Fajardo LF et al (1995) Overview: Late effects of normal tissues (LENT) scoring system. Int J Radiat Oncol Biol Phys 3:1041-1042
19. Cox JD, Stetz JA, Pajak TF (1995) Toxicity criteria of radiation therapy oncology group (RTOG) and European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31:1341-1346
20. Fuentes R, Canals E, Vayreda J (2003) Tratamientos de soporte en oncología radioterápica. Servicio de Oncología Radioterápica. Institut Catalá d'Oncologia, Girona (9):40-43
21. Sanchiz F, Millá A (1996) Prevention with orgotein of radioinduced secondary effects in patients with head and neck tumours. VIII Biennial Meeting International Society for Free Radical Research, Paris, France
22. Perderau B, Campana F, Vilcoq JR et al (1994) Superoxyde dismutase (Cu/ Zn) en application cutanée dans le traitment des fibrose radioinduites. Bull Cancer 81:659-669
23. Benyahia B, Campana F, Perderau B et al (1996) Effects of superoxide dismutase topical treatment on human skin radiofibrosis: A pathological study. Breast 5:75-81
24. Campana F, Zervoudis S, Perdereau B et al (2004) Topical superoxide dismutase reduces post-irradiation breast cancer fibrosis. J Cel Mol Med 8:109-116
25. Valencia J, Bascon N, Polo S et al (2000) Orgotein impact on radiotherapy acute side effects in head and neck cancer. Radiother Oncol 56:411
26. Valencia J, Velilla C, Urpegui A et al (2002) The efficacy of orgotein in the treatment of acute toxicity due to radiotherapy on head and neck tumors. Tumori 88:385-389